{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} New Paradigms in the Treatment of Cervical Cancer *6186*

Activity Steps

1 Activity
2 Take Test 3Certificate

Description

Cognate Code 6186

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Outline current screening and vaccination programs for cervical cancer and their effectiveness, and limitations, especially in resource-poor settings.
  2. Discuss changes in the surgical management, novel therapy options, and treatments for recurrent cervical cancer.
  3. Implement improved primary treatment options in your practice, including surgery for women with early-stage disease, modification of chemoradiation for those with locally advanced cervical cancer, and systemic therapy for those with recurrent or metastatic presentations.

Disclosures

Financial Disclosure: Charles A. Leath has received funding from the NIH UG1 CA23330 and P50 CA098252, contracted research with Agenus and Seattle Genetics, and served on a scientific advisory board for Seattle Genetics. He also indicated that tisotumab vedotin-tftv has accelerated approval pending confirmatory studies, as noted in this article. The other authors did not report any potential conflicts of interest.

Price: $25.00

Credits:

  • ACOG 2.0 CME

The American College of Obstetricians and Gynecologists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credit(s) The American College of Obstetricians and Gynecologists designates this journal-based activity for a maximum of 2 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

College Cognate Credit(s) The American College of Obstetricians and Gynecologists designates this journal-based activity for a maximum of 2 Category 1 College Cognate Credits. The College has a reciprocity agreement with the AMA that allows AMA PRA Category 1 Credits TM to be equivalent to College Cognate Credits.

Planner
Professions: Physician
Test Code: ONG1223
Published: November 16, 2023
Expires: 12/31/2026
Sources: Obstetrics & Gynecology
Required Passing Score: 7/10 (70%)
Authors: Teresa K. L. Boitano, MD, Tavonna Kako, MD, and Charles A. Leath III, MD, MSPH
Categories: Gynecological , Management , Obstetrical , Women's Health
Specialties: OB/GYN
Topics: Cervical Cancer